Research Analysts’ Updated EPS Estimates for December 27th (AROW, ASMB, BFAM, FBLG, FLS, GALT, KYMR, LPTH, MASI, MMS)

Research Analysts’ updated eps estimates for Friday, December 27th:

Arrow Financial (NASDAQ:AROW) had its price target trimmed by Hovde Group from $34.50 to $32.00. They currently have a market perform rating on the stock.

Assembly Biosciences (NASDAQ:ASMB) had its neutral rating reiterated by analysts at HC Wainwright.

Bright Horizons Family Solutions (NYSE:BFAM) had its price target cut by The Goldman Sachs Group, Inc. from $162.00 to $142.00. They currently have a buy rating on the stock.

FibroBiologics (NASDAQ:FBLG) had its buy rating reaffirmed by analysts at D. Boral Capital. D. Boral Capital currently has a $16.00 target price on the stock.

Flowserve (NYSE:FLS) was downgraded by analysts at StockNews.com from a strong-buy rating to a buy rating.

Galectin Therapeutics (NASDAQ:GALT) had its neutral rating reiterated by analysts at HC Wainwright.

Kymera Therapeutics (NASDAQ:KYMR) had its outperform rating reiterated by analysts at Leerink Partners. The firm currently has a $60.00 price target on the stock.

LightPath Technologies (NASDAQ:LPTH) had its price target boosted by Lake Street Capital from $3.00 to $4.00. The firm currently has a buy rating on the stock.

Masimo (NASDAQ:MASI) had its price target raised by Raymond James from $170.00 to $194.00. Raymond James currently has an outperform rating on the stock.

Maximus (NYSE:MMS) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.

MakeMyTrip (NASDAQ:MMYT) had its price target raised by Bank of America Co. from $119.00 to $130.00. The firm currently has a buy rating on the stock.

Myers Industries (NYSE:MYE) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.

Northwest Pipe (NASDAQ:NWPX) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.

ON (NYSE:ONON) had its buy rating reiterated by analysts at UBS Group AG. UBS Group AG currently has a $63.00 target price on the stock.

Quad/Graphics (NYSE:QUAD) was downgraded by analysts at StockNews.com from a strong-buy rating to a buy rating.

Steven Madden (NASDAQ:SHOO) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.

State Street (NYSE:STT) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.

Bancorp (NASDAQ:TBBK) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.

Toronto-Dominion Bank (NYSE:TD) (TSE:TD) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.

Viracta Therapeutics (NASDAQ:VIRX) had its neutral rating reaffirmed by analysts at Rodman & Renshaw. They currently have a $0.25 target price on the stock, down from their previous target price of $3.50.